These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8731790)

  • 41. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
    Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P-glycoprotein expression in de novo acute myeloid leukemia.
    Del Poeta G; Venditti A; Aronica G; Stasi R; Cox MC; Buccisano F; Bruno A; Tamburini A; Suppo G; Simone MD; Epiceno AM; Del Moro B; Masi M; Papa G; Amadori S
    Leuk Lymphoma; 1997 Oct; 27(3-4):257-74. PubMed ID: 9402325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly acute myeloid leukemia patients as compared to a control group of younger patients are related to the maturation characteristic of blast cells.
    Kasimir-Bauer S
    Haematologica; 2005 Jan; 90(1):3. PubMed ID: 15644303
    [No Abstract]   [Full Text] [Related]  

  • 44. [Analysis of P-glycoprotein in patients with acute leukemias by flow cytometry].
    Funato T; Bando Y; Kato H; Tokuhiro H; Shimoda Y; Ohtani H
    Rinsho Byori; 1989 Aug; 37(8):899-904. PubMed ID: 2573746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [P-glycoprotein expression in radiation-associated acute myeloid leukemia].
    Bebeshko VH; Bazyka DA; Klymenko SV; Maznichenko OL; Holiarnik NA; Liaskovs'ka OV; Il'ienko IM; Tretiak NM; Vdovtsov OO; Serbinenko TM; Zubryts'ka TB; Zinchenko VN
    Lik Sprava; 2005; (3):29-32. PubMed ID: 16025673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia.
    Karászi E; Jakab K; Homolya L; Szakács G; Holló Z; Telek B; Kiss A; Rejtô L; Nahajevszky S; Sarkadi B; Kappelmayer J
    Br J Haematol; 2001 Feb; 112(2):308-14. PubMed ID: 11167823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of drug resistance in acute myeloid leukemia.
    Zhang J; Gu Y; Chen B
    Onco Targets Ther; 2019; 12():1937-1945. PubMed ID: 30881045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The study of mechanisms of accumulation of daunorubicin and rodamin-123 in cells of human venous blood using cytometry technique].
    Gorbenko AS; Olkhovskii IA
    Klin Lab Diagn; 2015 Feb; 60(2):36-42. PubMed ID: 26027258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AML-derived Extracellular Vesicles Confer
    Barzegar M; Allahbakhshian Farsan M; Amiri V; Mohammadi S; Shahsavan S; Mirzaeian A; Mohammadi MH
    Iran J Pharm Res; 2021; 20(1):384-397. PubMed ID: 34400967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy resistance in acute myeloid leukaemia.
    Sonneveld P; List AF
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):211-33. PubMed ID: 11355932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.
    Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O
    Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Predictive value of intracellular accumulation of daunorubicin and P-glycoprotein expression simultaneously determined by flow cytometry in adult acute myeloid leukemias].
    Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Guerci O
    Ann Biol Clin (Paris); 1996; 54(1):17-9. PubMed ID: 8731790
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.